Clinical Trials Browser

OTHER × Antibodies, Monoclonal × Clear all

NCT01857934 2026-04-16

Therapy for Children With Advanced Stage Neuroblastoma

Phase 2 Completed

153 enrolled 12 charts

Neuroblastoma

NCT06366347 2026-02-11

ALPINE: Maintenance Letrozole/Abemaciclib

Phase 2 Recruiting

Endometrial Neoplasms

NCT06550141 2025-11-14

Emapalumab Prevention of CAR-T Cell Associated Toxicities

Phase 2 Recruiting

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT07033663 2025-08-15

NEWbornIMMPACT

Pregnancy Related

NCT07051850 2025-07-15

Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies

Multiple Myeloma, Recurrence

NCT06796517 2025-01-28

Immunotherapy in Lymphoma

Burkitt Lymphoma, Recurrence, Lymphoma, B-Cell

NCT05462496 2024-10-15

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT03942224 2024-06-21

DeRIVE

Phase 2 Active not recruiting

Multiple Myeloma

NCT06115174 2023-11-02

CRC - PTX

Phase 4 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT01873833 2023-10-05

Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer

Phase 2 Terminated

10 enrolled 16 charts

Breast Neoplasms

NCT05073250 2023-05-12

IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT03112590 2023-04-19

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

Phase 1/2 Completed

51 enrolled 13 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT02713373 2022-10-06

Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery

Phase 1/2 Completed

45 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

NCT04315467 2022-06-16

Intraoperative Imaging of Pulmonary Nodules by SGM-101

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02254941 2022-03-16

Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer

Gastrointestinal

Colonic Neoplasms

NCT02855086 2020-03-31

Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery

Phase 1/2 Terminated

3 enrolled 7 charts

Brain Neoplasms, Glioma

NCT01136395 2019-10-08

Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

Phase 2 Completed

Virus Diseases, Epstein-Barr Virus Infections

NCT00681993 2019-01-22

PBIC

Phase NA Completed

Breast Neoplasms

NCT03631836 2018-08-17

MARELLE01

Phase 1 Unknown

Glioblastoma

NCT00989586 2017-02-06

Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Phase 1/2 Completed

35 enrolled 11 charts

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00052403 2014-01-16

Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00142155 2011-06-27

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

Phase NA Completed

Waldenstrom Macroglobulinemia

NCT00515892 2007-08-14

NHL

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin